EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel extraction-free dual HiFi-LAMP assay for detection of methicillin-sensitive and methicillin-resistant Staphylococcus aureus

Xiuli Zhao, Yi Zeng, Beibei Yan, Yanping Liu, Yueqin Qian, Aiping Zhu, Yongjuan Zhao, Xiaoling Zhang, Chiyu Zhang iD, Zhenzhou Wan iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.04133-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Xiuli Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Laboratory of Taizhou Fourth People's Hospital, Taizhou, China. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections, Cross Infection, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: STCSM | Science and Technology Innovation Plan of Shanghai Science and Technology Commission (), Science and Technology Support Foundation of Taizhou city.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Staphylococcus aureus ( S. aureus ) is a leading cause of bacteremia and blood stream infections. Methicillin-resistant S. aureus (MRSA) that first appeared in 1961 often caused hospital-acquired infections (HAIs) and community-acquired infections (CAIs) and was associated with high mortality rate. Accurate and rapid point-of-care testing (POCT) of MRSA is crucial for clinical management and treatment of MRSA infections, as well as the prevention and control of HAIs and CAIs. Here, we reported a novel extraction-free dual HiFi-LAMP assay for discriminative detection of methicillin-susceptible S. aureus and MRSA. The dual HiFi-LAMP assay can detect 30 copies/reaction of nuc and mecA genes with detection limits of 147 and 158 copies per 25 µL reaction, respectively. A retrospective clinical evaluation with 107 clinical S. aureus isolates showed both sensitivity and specificity of 100%. A prospective clinical evaluation with 35 clinical samples revealed a specificity of 100% and a sensitivity of 92.3%. The dual HiFi-LAMP assay can detect almost all S. aureus samples (141/142; 99.3%) within 20 min, implying that the entire HiFi-LAMP assay (including sample process) can be completed within 40 min, extremely significantly shorter than 3–5 days by the traditional clinical microbial culture and antibiotic susceptibility testing. The novel extraction-free dual HiFi-LAMP assay can be used as a robust POCT tool to promote precise diagnosis and treatment of MRSA infections in hospitals and to facilitate surveillance of MRSA at hospital and community settings. IMPORTANCE Methicillin-resistant Staphylococcus aureus (MRSA) was associated with high mortality rate and listed as a “priority pathogen” by the World Health Organization. Accurate and rapid point-of-care testing (POCT) of MRSA is critically required for clinical management and treatment of MRSA infections. Some previous LAMP-based POCT assays for MRSA might be questionable due to their low specificity and the lack of appropriate evaluation directly using clinical samples. Furthermore, they are relatively tedious and time-consuming because they require DNA extraction and lack multiplex detection capacity. Here, we reported a novel extraction-free dual HiFi-LAMP assay for discriminative detection of MRSA and methicillin-susceptible S. aureus . The assay has high specificity and sensitivity and can be completed within 40 min. Clinical evaluation with real clinical samples and clinical isolates showed excellent performance with 100% specificity and 92.3%–100% sensitivity. The novel extraction-free assay may be a robust POCT tool to promote precise diagnosis of MRSA infections and facilitate surveillance of MRSA at hospital and community settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsCross InfectionNucleic Acid Amplification TechniquesMolecular Diagnostic TechniquesHumansMethicillinStaphylococcus aureusProspective StudiesRetrospective StudiesBacterial ProteinsAnti-Bacterial AgentsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

HiFi-LAMPMRSAPOCTS. aureusmecA genenuc genespecificity

Substanzen

MethicillinBacterial ProteinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Medical Laboratory of Taizhou Fourth People's Hospital, Taizhou, China.
  • Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

ORCID-Profile: Chiyu Zhang, Zhenzhou Wan

Förderung

  • STCSM | Science and Technology Innovation Plan of Shanghai Science and Technology Commission ()
  • Science and Technology Support Foundation of Taizhou city

Zitieren

APA

Zhao, X., Zeng, Y., Yan, B., Liu, Y., Qian, Y., Zhu, A., Zhao, Y., Zhang, X., Zhang, C., & Wan, Z. (2024). A novel extraction-free dual HiFi-LAMP assay for detection of methicillin-sensitive and methicillin-resistant Staphylococcus aureus. Microbiology Spectrum. https://doi.org/10.1128/spectrum.04133-23

Vancouver

Zhao X, Zeng Y, Yan B, Liu Y, Qian Y, Zhu A, et al. A novel extraction-free dual HiFi-LAMP assay for detection of methicillin-sensitive and methicillin-resistant Staphylococcus aureus. Microbiology Spectrum. 2024. doi:10.1128/spectrum.04133-23

BibTeX
@article{Zhao2024,
  author = {Zhao, Xiuli and Zeng, Yi and Yan, Beibei and Liu, Yanping and Qian, Yueqin and Zhu, Aiping and Zhao, Yongjuan and Zhang, Xiaoling and Zhang, Chiyu and Wan, Zhenzhou},
  title = {A novel extraction-free dual HiFi-LAMP assay for detection of methicillin-sensitive and methicillin-resistant Staphylococcus aureus},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.04133-23}
}
Kostenlos starten →